This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.
Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback